Population pharmacokinetics of cyclophosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy.
Wilde
S
S
Institut für Pharmakologie, Universität zu Köln, Klinische Pharmakologie, Germany. stefanwilde@hotmail.com
Jetter
A
A
Zaigier
M
M
Rietbrock
S
S
Menzel
H
H
Sieber
M
M
Tesch
H
H
Hempel
G
G
Busse
D
D
Schwab
M
M
Reif
S
S
Jaehde
U
U
Diehl
V
V
Fuhr
U
U
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D003520:Cyclophosphamide / Q000097:blood / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000097:blood / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005047:Etoposide / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological
D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide